Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Research: Compendia: Research Models: PS2 Mutations
NSE-hPS2(N141I) and hPS2wt

General Information

Transgene: The pNSE-hPS2w and pNSE-hPS2m were constructed by combining the NSE promoter containing SacI-SphI fragment from pNSE-CAT and the hPS2m (N141I, Volga German Families). Each SacII/XbaI fragment of hPS2w and hPS2m was inserted in pUHD10-3. The pNSE-CAT and pUHD10-3 were gifts of Dr. J. Gregor Sutcliffe and Dr. Tae-Wan Kim, respectively. Each linear NSE-PS2w and NSE-PS2m fragment was microinjected into pronucleus of fertilized BDF1mice eggs then transferred to the oviducts of pseudopregnant ICR recipient females.

Mutation: N141I

Promoter: NSE promoter

Strain: C57BL/6× DBA/2

Phenotype

Neuropathological analysis:

Levels of hPS2, Aβ-42, caspase-3, and Cox-2 expression were modulated in the brains of both wt and tg mice. Dense staining with antibody to hPS2, Aβ-42, caspase-3, and Cox-2 was visible in the brains of tg mice compared with age-matched controls, and distinguishable AD phenotypes between hPS2w- and hPS2m-Tg mice did not appear.

Behavioral:

Tg mice showed a behavioral dysfunction in the water maze test.

Availability

Yong K. Kim
Division of Laboratory Animal Resources
Korea FDA, National Institute of Toxicological Research
5 Nokbun-dong Eunpyng-ku
Seoul 122-704, Korea
Telephone: +82-2-380-1835
Fax: +82-2-380-1833
Email: kimyongkyu@hanmail.net

Patents: PS2-transgenic mice; Jung S. Cho / Yong K. Kim et al.; Filed 11/4/02

Reference

Primary:

Hwang DY, Chae KR, Kang TS, Hwang JH, Lim CH, Kang HK, Goo JS, Lee MR, Lim HJ, Min SH, Cho JY, Hong JT, Song CW, Paik SG, Cho JS, Kim YK. Alterations in behavior, amyloid beta-42, caspase-3, and Cox-2 in mutant PS2 transgenic mouse model of Alzheimer's disease. FASEB J. 2002 Jun;16(8):805-13. Abstract.

Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark

See recent updates
Alzheimer's Disease Mouse Model Resource
Considerations for Choosing Controls
Research Tools

Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad